Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2021

Mar 19, 2021

30339_dirs_2021-03-19_0a1655b7-6cec-4208-8b7d-3d485125592b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2021-03-12

Reporting Person: Winters Chad (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-12 Common Stock A 170.00 $261.62 Acquired 714.8868 Direct

Footnotes

F1: Portion of bonus paid in stock with a conversion date of March 8, 2021